LQV Branded Vial
Mazdutide
Includes syringes and alcohol pads with every vial shipment.
Mazdutide
Mazdutide is a dual GLP-1 and glucagon receptor agonist designed to promote weight loss through both appetite suppression and increased energy expenditure. It combines the satiety benefits of GLP-1 activation with the thermogenic and fat-burning effects of glucagon signaling.
How It Works
Mazdutide activates GLP-1 receptors to reduce appetite and slow gastric emptying while simultaneously engaging glucagon receptors to boost resting energy expenditure and promote hepatic fat oxidation. This dual mechanism supports weight loss from both the intake and expenditure sides of the energy balance equation.
Key Benefits
Who It Is For
Adults with obesity or overweight conditions who are seeking a therapy that addresses both caloric intake and energy expenditure. Suitable for patients who want a dual-mechanism approach without the triple-receptor complexity. Medical evaluation and monitoring are required.
Common Side Effects
Common side effects include nausea, diarrhea, vomiting, and reduced appetite. Glucagon receptor activation may cause mild elevations in heart rate or transient blood sugar changes. Serious side effects are uncommon but are fully reviewed during the consultation process.
Other GLP-1 Therapies
GLP-1 Therapy
Semaglutide
(SMA)
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes management and now widely used for weight management. It helps reduce appetite, slow gastric emptying, and promote sustainable weight loss when combined with lifestyle modifications.
From $299
GLP-1 Therapy
Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist that targets two incretin pathways simultaneously. It has demonstrated significant efficacy in clinical weight loss trials and offers enhanced metabolic benefits compared to single-receptor therapies.
From $399
GLP-1 Therapy
Retatrutide
(RTA)
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors. By engaging three metabolic pathways, it represents the next generation of weight management therapies with the potential for greater efficacy in both weight loss and metabolic improvement.
From $449
Frequently Asked Questions
A therapy that mimics natural gut hormones involved in appetite and blood sugar regulation.
Yes. Medical evaluation and monitoring are required for all GLP-1 therapies.
Yes, following medical review and protocol setup.
Yes. Use the Speak To Our Medical Team tab to submit a form and request a consultation.
Prescription therapies require medical evaluation and supervision. Results vary. Side effects and risks are discussed during consultation.